We specialize in the development of innovative products for patients with
urological ailments including, specifically, the development of innovative
products for amelioration of Bladder Pain Syndrome/Interstitial Cystitis ("BPS"
Urology represents a specialty pharmaceutical market of, according to the
American Urology Association (the "AUA"), approximately 10,000 physicians in the
United States. Urologists treat a variety of ailments of the urinary tract
including urinary tract infections, bladder cancer, overactive bladder, urgency
and incontinence and interstitial cystitis, a subset of BPS. Many of these
indications, we believe, represent significant, underserved therapeutic market
Over the next several years, we believe, a number of key demographic and
technological factors should accelerate growth in the market for medical
therapies to treat urological disorders, particularly in our product categories.